Skip to content

Tandem Diabetes Care Inc

TNDM· NasdaqCore metricsCIK 1438133

Surgical & medical instruments & apparatus142 peers

Last sale
Nov 12, 2026 · -6.66%
Market cap
$1.22B
69.79M shares
Filings
1,040
$283.69M
Q3 2026+7.9% FY25 yoy
-$7.09M
Q3 2026N/M FY25 yoy
-$2.37M
Q3 2026N/M FY25 yoy
-$39.40M
Q3 2026derivedN/M FY25 yoy
-$0.10
Q3 2026N/M FY25 yoy
$72.84M
Q3 2026+30.9% FY25 yoy
$1.22B
—
1.1×
9.1×
-2.97%
—

Twelve months to Sep 30, 2026 · derived

Price

$17.520.06%$0.01past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of record

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$1.01BFY 2025
$1.01B0FY 2014FY 2019FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$1,014,736,000reported
FY 20242024-12-31$940,203,000reported
FY 20232023-12-31$747,718,000reported
FY 20222022-12-31$801,217,000reported
FY 20212021-12-31$702,799,000reported
FY 20202020-12-31$498,830,000reported
FY 20192019-12-31$362,305,000reported
FY 20182018-12-31$183,866,000reported
FY 20172017-12-31$107,601,000reported
FY 20162016-12-31$84,248,000reported
FY 20152015-12-31$72,850,000reported
FY 20142014-12-31$49,722,000reported

Capital returns

Dividends and buybacks · FY2022 to FY2025
Fiscal yearDividendsBuybacksTotalPer shareSharesShares · yoyof free cash flow
FY2025—$0.00$0.00—68.33M sh+2.8%—
FY2024—$30.00M$30.00M—66.47M sh+1.3%600.7%
FY2023—$0.00$0.00—65.63M sh+1.7%—
FY2022—$0.00$0.00—64.53M sh+1.0%0.0%

Segments

Revenue by Geography, FY2018 to FY2025FY2018United States · FY2018 · $174.19MInternational · FY2018 · $9.68MFY2019United States · FY2019 · $302.08MInternational · FY2019 · $60.22MFY2020United States · FY2020 · $415.68MInternational · FY2020 · $83.15MFY2021United States · FY2021 · $524.91MInternational · FY2021 · $177.89MFY2022United States · FY2022 · $588.77MInternational · FY2022 · $212.45MFY2023United States · FY2023 · $554.88MInternational · FY2023 · $192.84MFY2024United States · FY2024 · $672.69MInternational · FY2024 · $267.52MFY2025United States · FY2025 · $706.94MInternational · FY2025 · $307.80M
LineFY2025ShareChange
United States$706.94M70%+5.1%
International$307.80M30%+15.1%
Total$1.01B

From the 10-K filed Feb 19, 2026TNDM

Surgical & medical instruments & apparatus

Tandem Diabetes Care Inc is the 21st largest of the 143 covered companies the SEC files under this code, by revenue. SIC 3841

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Tandem Diabetes Care Inc · CIK 1438133 · Engraved from SEC EDGAR